AUTHOR GUIDELINES

1. GENERAL

The MicroMedicine (MM) is a peer-reviewed, Open-Access, article-based, international, scientific Journal, that publishes full-length articles on life sciences. Journal accepts original research articles, case reports and review articles. The MM is issued quarterly in electronic version. Public access to all articles is free of charge.

2. ETHICAL GUIDELINES

2.1. Authorship and Acknowledgements

Authors submitting a paper do so on the understanding that the manuscript have been read and approved by all authors and that all authors agree to the submission of the manuscript to the Journal.

2.2. Ethical Approvals

We abide by Code of Conduct by Committee on Publication Ethics (COPE) and aim to adhere to its Best Practice Guidelines.

When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983. Do not use patients’ names, initials, or hospital numbers, especially in illustrative material. Papers including animal experiments or clinical trials must be accompanied by an approval by the local ethics committee. Please give date of issue and registration number. Make sure that reporting of random controlled trials complies with the CONSORT guidelines, and that such manuscripts include a flow chart along with a completed checklist when submitted - both available on the world wide web (http://www.consort-statement.org).

2.3. “Ghostwriting” and “guest authorship” prevention

The editors of MM lead the policy of “ghostwriting” and “guest authorship” prevention.

“Ghostwriting” is the case of contributing a publication without revealing one’s participation as one of the authors or without reference to their role in the acknowledgments in the publication.

“Guest authorship” (honorary authorship) is the case of insignificant contribution of the author or its complete absence and nevertheless being the author or co-author of the publication.

The editors reserve the right to reveal all aspects of scientific dishonesty, i.e. failure to comply with actions eliminating the occurrence of the aforementioned practices.

The editors require that Authors should reveal individual co-authors’ contribution to the publication. Potential contributions include:

• Conception and design
• Development of methodology
• Acquisition of data
• Analysis and interpretation of data
• Writing, review and/or revision of the manuscript
• Administrative, technical, or material support
• Study supervision
• Other

However, the author submitting the manuscript will chiefly be held responsible. (The ghostwriting and guest authorship prevention procedure in MM was written according to the guidelines of the Ministry of Science and Higher Education)

2.4. Plagiarism

Plagiarism is when an author attempts to pass off someone else's work as his or her own. Duplicate publication, sometimes called self-plagiarism, occurs when an author reuses substantial parts of his or her own published work without providing the appropriate references. By submitting your manuscript to us you accept that your manuscript may be screened for plagiarism against previously published works.

Manuscripts that are found to have been plagiarized will incur plagiarism sanctions:

- immediate rejection of the submitted manuscript or published article

- no return of article-processing charge

- prohibition against all of the authors for any new submissions.

2.5. Withdrawal of manuscripts

The Committee on Publication Ethics (COPE) published international standards of publication ethics for the authors and these standards have also been adopted by the journals appearing in the international scientific indices. According to these standards, if an authors request to withdraw their already submitted article for publishing to a journal, a letter signed by all authors stating their request and reasons for withdrawal must be sent to journal editor regardless of the stage of the editorial or review process. Manuscript can be withdrawn only with the permission of the editor. However, it is unethical to withdraw a submitted manuscript from one journal if accepted by another journal. The withdrawal of manuscripts from the journal after submitting to the publisher will incur a withdrawal penalty. After the manuscript is accepted for publication the withdrawal is not permitted by TMKarpiński Publisher. If the authors withdraw manuscript submitted to TMKarpiński Publisher for processing, the request is not entertained without a significant withdrawal penalty. Authors are not allowed to withdraw submitted manuscripts because the withdrawal wastes valuable manuscript processing time, money and works invested by the Publisher and reviewers. The authors must always pay EUR 200 per manuscript processing charges as withdrawal penalty to the Publisher even if the withdrawal is permitted. Withdrawal of manuscripts is only allowed after withdrawal penalty has been fully paid to the TMKarpiński Publisher by the authors.

2.6. Conflict of Interest and Sources of Funding

Authors are requested to provide a statement concerning any commercial associations or patent licenses that might result in a conflict of interest with the work presented in the submitted paper.

2.7. Permissions

Materials copied from other sources must be accompanied by a written statement from both the author and publisher giving permission to MicroMedicine for reproduction. It is the author’s responsibility to ensure that such permissions are obtained.

2.8. Copyright Assignment

Authors submitting a paper do so on the understanding that the work and its essential substance have not been published before and is not being considered for publication elsewhere. The articles published in this journal are open-access articles distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

3. MANUSCRIPT SUBMISSION PROCEDURE

3.1. Cover Letter

Each manuscript should be accompanied by a Cover Letter. The cover letter should contain all important details such as: your full name (submitted by), full title of article and short title, full list of authors with affiliations, e-mail of the corresponding author, contact address, telephone/fax numbers of the corresponding author. In the cover letter Authors should propose 3-5 reviewers giving names, affiliations and e-mails.

All authors of the manuscript are responsible for its content; they must have agreed to its publication and have given the corresponding author the authority to act on their behalf in all matters pertaining to publication. The corresponding author is responsible for informing the coauthors of the manuscript status throughout the submission, review, and production process.

3.2. Manuscript Files Accepted

The final version of the manuscript, figures and tables should be submitted by site http://www.journals.tmkarpinski.com/index.php/mmed

Main text and tables must be in Microsoft Word (.doc) format (not write-protected).

Photographs, drawings and graphs must be original and must be in JPG or TIFF format, preferred resolution >300 dpi.

The manuscript must be accompanied by: a written Licence Form, and in case of experimental studies a statement that the protocol of study and informed consent were in compliance with the Helsinki Convention and were approved by local Ethics Committee. Upon acceptance of the manuscript, the author(s) will be asked to send Licence Form to the publisher.

3.3. Review

All submitted manuscripts are confidential until published. All submitted manuscript will be reviewed by at least one expert in the field, who is from behind of scientific unit in which is affiliated author of the publication. Papers that do not conform to the general aims and scope of the journal will, however, be returned immediately without review. The names of the reviewers will not be disclosed to the author submitting a paper. Peer review comments are confidential and will only be disclosed with the express agreement of the reviewer.

3.4. E-mail Confirmation of Submission

After submission you will receive an automatic e-mail to confirm receipt of your manuscript. If you do not receive the confirmation e-mail, please check your e-mail address carefully in the system. The error may be caused by some sort of spam filtering on your e-mail server.

3.5. Manuscript Status

The Journal will inform you by e-mail once a decision has been made.

Current status of manuscript you can check in: Submission -> Review -> Editor Decision. Rejected manuscripts are marked as: "Decline Submission" or "Archived".

3.6. Submission of Revised Manuscripts

To submit a revised manuscript, send it by e-mail: cls@interia.eu

4. MANUSCRIPT TYPES ACCEPTED

MicroMedicine publishes original research articles, short communications, case reports and reviews.

Original Research Articles must describe significant and original experimental observations and provide sufficient detail so that the observations can be critically evaluated and, if necessary, repeated.

Short Communications are intended for the presentation of brief observations that do not warrant a full-length papers. 

Case Reports must describe an individual phenomenon, uncommon case or a new or improved method.

Reviews are selected for their broad general interest; should take a broad view of the field.

5. MANUSCRIPT FORMAT AND STRUCTURE

5.1. Language

The language of publications is English. Authors whose native language is not English are strongly advised to have their manuscripts checked by a professional translator or a native speaker prior to submission.

5.2. Structure

All articles should include Title Page, Abstract, and References and in addition sections on Source of Funding and Conflict of Interests. Figures, Figure Legends and Tables should be included where appropriate.

Title Page: The title must contain no more than 100 characters including spaces. The title page should include a running title of no more than 40 characters; 5-10 key words, complete names of institutions for each author, and the name, address, telephone number, fax number and e-mail address for the corresponding author.

Conflict of Interest and Source of Funding: Authors are requested to provide a statement concerning any commercial associations or patent licenses that might result in a conflict of interest with the work presented in the submitted paper. Author's conflict of interest (or the absence of conflicts of interest) and the sources of funding for the research will be published under a heading "Conflict of Interest and Source of Funding Statement".

Abstract: is limited to 250 words in length and should not contain abbreviations or references.

Acknowledgements: Under acknowledgements please specify contributors to the article other than the authors accredited.

5.3. Original Research Articles

Main Text should be organized with Introduction, Materials and Methods, Results, Discussion (or Results and Discussion). The background and hypotheses underlying the study, as well as its main conclusions, should be clearly explained.

5.4. Short Communications

These must have an abstract of no more than 100 words. Manuscript should be formatted without section headings in the body of the text. All the required parts (introduction, methods, results and discussion) except for the Literature must be given in single section. Total length should not exceed 10 printed pages including illustrative material (no more than 3 figures and tables).

5.5. Case Report Articles

These should be divided into the following sections: Title page, Abstract, Introduction, Case presentation, Discussion, Conclusions.

5.6. Review Articles

Reviews should take a broad view of the field rather than merely summarizing the authors´ own previous work. The use of state-of-the-art evidence-based systematic approaches is expected. Main text should be organized with Introduction, Review, Conclusions.

5.7. References

Citations in the text should be marked by Arab numbers in square brackets.

a) The arrangement of the references should be in consecutive order (as they are cited in the text).

b) The first six authors should be presented; if are more than six, please use a phrase: et al.

c) The order of the items in each reference should be as in examples:

Article
Nowak MA, Kowalski A. Natural antibiotics. J Biol Earth Sci. 1992; 4(1): E1-E6.

Book
Nowak Z, Huber A, eds. Moss flora of Poznań. 4th edn. Warszawa, Scientific Publishing, 2003.

Chapter from a Book
Kowalski T. 1980. Skin infections. In: White CG, Belkov MN, eds. Microbiology for students. New York, PublishMe, 2005: 53-65. 

Non-English Language
Lapuyade G, Loustau JM. Spontaneous regression of disk herniation: apropos of 7 cases [in French]. J Radiol 1989; 70: 697-702. 

5.8. Tables and Figures

Tables: should be with no vertical rulings, with a single bold ruling beneath the column titles. Units of measurements must be included in the column title. Max. format A4, only in a vertical arrangement.

Figures: All figures should be planned to fit within either 1 column width (8.2 cm) or 2 column widths (17.0 cm). Lettering on figures should be in a clear typeface; the same typeface should be used for all figures.

Units should have a single space between the number and the unit, and follow SI nomenclature or the nomenclature common to a particular field (defined in the legend). Do not use pixel-oriented programmes.

Permissions: If all or parts of previously published illustrations are used, permission must be obtained from the copyright holder concerned. It is the author's responsibility to obtain these in writing and provide copies to the Publishers.

6. REVISION AND ACCEPTANCE OF THE MANUSCRIPT

6.1. Revision of the manuscript

Finally, journal editors make decisions to accept or reject papers based on their opinion of the papers’ publication worthiness and reviewers’ comments.

Revised manuscript must be submitted within 2 months from the date of receipt of the comments of reviewers.

Upon acceptance of a paper for publication, the manuscript will be forwarded to the production of the journal.

6.2. Proof Corrections

The corresponding author will receive an email with the proof PDF file. Corrected proof must be scanned and returned to the Editor within 7 working days. Excessive changes made by the author in the proof, excluding typesetting errors, will be charged separately. Please note that the corresponding author is responsible for all statements made in his work, including changes made by the copy editor. Manuscripts submitted under multiple authorship are published on the assumption that the final version of the manuscript has been seen and approved by all authors.

6.3. Article-processing charge

Publication in MicroMedicine is free of charge.

6.4. Online publication

Online publication will normally be within 2 weeks of receipt of corrected proof by the TMKarpinski Publisher. Authors should note that online articles are complete and final and thus no changes can be made after online publication.

PRIVACY STATEMENT

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.